Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Study of CD4-Targeted Chimeric Antigen Receptor T-Cells (CD4- CAR-T) in Subjects With Relapsed or Refractory T-Cell Lymphoma

Legend Biotech USA Inc · 2021
ClinicalTrials.gov · Datasets · License: Public Domain · 2021
Open Source ↗
t-cell lymphoma, peripheral t-cell lymphoma refractory, cutaneous t-cell lymphoma refractory, cutaneous t-cell lymphoma recurrent, peripheral t-cell lymphoma recurrent, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1009395
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.